CA Patent

CA2375779A1 — Lyophilized hgf preparation

Assigned to Mitsubishi Chemical Corp · Expires 2000-12-07 · 25y expired

What this patent protects

Freeze dried preparations containing hepatocyte growth factor (HGF), a stabilizer such as arginine or lysine, sodium chloride and a buffer. These preparations, which are produced from an aqueous solution containing less th an 5 mg/mL of HGF and/or to be used in producing an aqueo…

USPTO Abstract

Freeze dried preparations containing hepatocyte growth factor (HGF), a stabilizer such as arginine or lysine, sodium chloride and a buffer. These preparations, which are produced from an aqueous solution containing less th an 5 mg/mL of HGF and/or to be used in producing an aqueous solution containing less than 5 mg/mL of HGF, are excellent in storage stability.

Drugs covered by this patent

Patent Metadata

Patent number
CA2375779A1
Jurisdiction
CA
Classification
—
Expires
2000-12-07
Drug substance claim
No
Drug product claim
No
Assignee
Mitsubishi Chemical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.